VitaNova Life Sciences (VNOV) Cost of Revenue (2017 - 2025)
VitaNova Life Sciences (VNOV) posted Cost of Revenue of $166312.0 for Q4 2025, up 373.58% on a QoQ basis from $35118.0 in Q3 2025, and up 104498.74% year-over-year from N/an in Q4 2024.
VitaNova Life Sciences (VNOV) Cost of Revenue (2017 - 2025) Analysis & Trends
VitaNova Life Sciences' Cost of Revenue history runs 3 years deep, the most recent figure standing at $166312.0 for Q4 2025.
- Quarterly Cost of Revenue rose 104498.74% year-over-year to $166312.0 in Q4 2025, while the trailing twelve-month figure through Jan 2026 was $997231.0 (up 1606.24% YoY) and the FY2025 annual result came in at $1.1 million, up 4689.47% from the prior year.
- Cost of Revenue was $166312.0 for Q4 2025 at VitaNova Life Sciences, up from $35118.0 in the prior quarter.
- Across five years, Cost of Revenue topped out at $795801.0 in Q2 2025 and bottomed at $159.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 105.15 Bn | 101.18 Bn | 4.04 Bn | 92.25 Bn |
| 2 | Cencora | 60.58 Bn | 58.40 Bn | 3.59 Bn | 74.77 Bn |
| 3 | Cardinal Health | 53.81 Bn | 49.87 Bn | 2.50 Bn | 58.44 Bn |
| 4 | Henry Schein | 9.71 Bn | 9.57 Bn | 1.07 Bn | 2.30 Bn |
| 5 | Akso Health | 3.28 Bn | 3.28 Bn | - | - |
| 6 | 111 | 651.73 Mn | 572.63 Mn | 23.58 Mn | 379.70 Mn |
| 7 | Accendra Health | 248.02 Mn | -88.86 Mn | 278.03 Mn | 349.75 Mn |
| 8 | Edap Tms | 230.14 Mn | 215.14 Mn | 8.15 Mn | 9.67 Mn |
| 9 | VitaNova Life Sciences | 11.51 Mn | 11.01 Mn | 316,343.00 | - |
| 10 | Cosmos Health | 9.57 Mn | 7.41 Mn | 1.38 Mn | 16.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | 166,312.00 |
| Oct 31, 2025 | 166,312.00 |
| Jul 31, 2025 | 35,118.00 |
| Jul 31, 2025 | 35,118.00 |
| Apr 30, 2025 | 795,801.00 |
| Apr 30, 2025 | 795,801.00 |
| Jan 31, 2025 | 300.00 |
| Jan 31, 2025 | 300.00 |
| Oct 31, 2024 | 159.00 |
| Oct 31, 2024 | 159.00 |
| Jul 31, 2024 | 35,304.00 |
| Jul 31, 2024 | 35,304.00 |
| Apr 30, 2024 | 22,683.00 |
| Apr 30, 2024 | 22,683.00 |
| Oct 31, 2017 | 31,300.00 |
| Oct 31, 2017 | 31,300.00 |
| Jul 31, 2017 | 2,900.00 |
| Jul 31, 2017 | 2,900.00 |